ADBiotech Co., Ltd. (KOSDAQ:179530)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,100.00
+585.00 (23.26%)
At close: Apr 3, 2026
Market Cap61.01B +288.3%
Revenue (ttm)12.90B +15.8%
Net Income-3.30B
EPS-275.00
Shares Out19.68M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,847,110
Average Volume654,242
Open2,535.00
Previous Close2,515.00
Day's Range2,535.00 - 3,265.00
52-Week Range1,300.00 - 5,450.00
Beta0.30
RSI71.93
Earnings DateMar 27, 2026

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 179530
Full Company Profile

Financial Performance

In 2025, ADBiotech's revenue was 12.90 billion, an increase of 15.81% compared to the previous year's 11.14 billion. Losses were -3.30 billion, -58.45% less than in 2024.

Financial Statements